SPECT/CT Bone Scan Quantification Surgery
PERQUAL
Predictive Performance of SPECT/CT Bone Scan Quantification Before Lumbar Arthrodesis
1 other identifier
interventional
70
1 country
1
Brief Summary
The hypothesis of our study is that SPECT/CT bone scan fixation quantified by SUVMAX on a CZT solid state camera preoperatively would identify good responders to lumbar arthrodesis surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 21, 2021
CompletedFirst Posted
Study publicly available on registry
January 10, 2022
CompletedStudy Start
First participant enrolled
April 29, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 29, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 29, 2025
CompletedJanuary 8, 2025
January 1, 2025
3.6 years
December 21, 2021
January 7, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
To determine if there is a correlation of SUV value and response to surgery with ODI
To determine whether SUVmax (Standard Uptake Value) measured at late time on bone scan, predicts a good response to lumbar arthrodesis surgery according to the Oswestry Disability Index (ODI) measured at 12 months after surgery
24 months
Secondary Outcomes (3)
To determine if there is a correlation of SUV value and response to surgery with NS
24 months
To determine if there is a correlation of SUV value at early time and response to surgery with ODI
24 months
To determine if there is a correlation of SUV value at early time and response to surgery with NS
24 months
Study Arms (1)
Patients
EXPERIMENTALPatients with bone scan
Interventions
Persons to be operated on for lumbar arthrodesis by the neurosurgery team of the Nancy CHRU and respecting the eligibility criteria (including a score of neuropathique pain scale \< 4, see non-inclusion criteria), will be proposed to participate in the study neuropathic pain If they give their oral agreement to the neurosurgeon, a request for a bone scan will be sent to the nuclear medicine department of the Nancy-Brabois Hospital. The patients will fill pain scales before and after surgery (ODI and NS)
Eligibility Criteria
You may qualify if:
- Persons with back pain for at least 3 months (presumed to be due to degenerative disc disease or spondylolisthesis).
- Persons who have received full information about the organisation of the research and have signed the informed consent and :
- Age ≥ 18 years, having read and understood the information document.
- Affiliated to a social security scheme.
- Lumbar arthrodesis involving a maximum of 2 floors.
- Standardized lumbar arthrodesis surgery performed by one of the three senior neurosurgeons of the neurosurgery department of the Nancy CHRU, using similar surgical techniques.
You may not qualify if:
- Low back pain of neuropathic origin. The Neuropathic Pain Scale 4 questionnaire is used to diagnose neuropathic pain (score is ≥ 4/10)
- History of lumbar spine surgery
- Presence of other pathologies responsible for lumbar pain (multistage discopathies, ankylosing spondylitis, spondylodiscitis, rheumatoid arthritis, vertebral compression, vertebral metastasis, narrow lumbar canal, scoliosis, spondylolisthesis by isthmic lysis)
- Pregnant women or women of childbearing age without suitable contraception or nursing mothers.
- Unstable medical condition and/or inability to remain immobile in supine position during recordings.
- Known allergy to any component of the radiopharmaceutical (TECHNESCAN HDP).
- Person referred to in Articles L. 1121-5, L. 1121-7 and L1121-8 of the Public Health Code.
- Persons deprived of their liberty by a judicial or administrative decision, persons under psychiatric care by virtue of Articles L. 3212-1 and L. 3213-1.
- Persons of full age who are unable to express their opposition.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nuclear Medicine Department
Vandœuvre-lès-Nancy, 54511, France
Study Officials
- STUDY DIRECTOR
El Mehdi SIAGHY, PhD
CHRU Nancy
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
December 21, 2021
First Posted
January 10, 2022
Study Start
April 29, 2022
Primary Completion
November 29, 2025
Study Completion
November 29, 2025
Last Updated
January 8, 2025
Record last verified: 2025-01